API site WHO GMP risk during WHO inspection – avoiding repeat WHO observations



Published on 28/01/2026

Mitigating API Site Risks During WHO Inspections: A Practical Playbook

Pharmaceutical manufacturers face a growing imperative to maintain compliance with WHO Good Manufacturing Practice (GMP) standards. The increasing scrutiny during WHO inspections makes it essential to identify and mitigate risks that can lead to non-compliance and repeat observations. This article provides a comprehensive playbook aimed at maximizing compliance readiness and minimizing the potential for WHO GMP-related issues. By following this guide, you will understand how to identify risks, implement effective controls, and ensure your documentation is inspection-ready.

The goal of this playbook is to equip Quality Assurance (QA), Quality Control (QC), Production, Engineering, and Regulatory Affairs (RA) teams with actionable steps, potential investigation workflows, and useful tools. This approach will enhance your readiness for WHO inspections while also ensuring ongoing compliance with GMP and regulatory expectations.

Symptoms/Signals on the Floor or in the Lab

Identifying symptoms or signals indicating potential GMP deviations is crucial for timely interventions. Here are common indicators observed during API

manufacturing processes:

  • Increased Deviation Reports: A rise in the number of out-of-specification (OOS) results or deviations noted in batch records.
  • Equipment Malfunctions: Frequent machine breakdowns, leading to unplanned downtimes, can compromise product quality.
  • Contamination Events: Instances of cross-contamination or microbial outbreaks, particularly in sterile manufacturing environments.
  • Employee Complaints: Feedback from operators about process inefficiencies or safety concerns can highlight deeper systemic issues.
  • Audit Findings: Previous audit outcomes revealing repeat observations or trends, which can indicate inadequate corrective actions.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding the potential causes of non-compliance is critical for developing a targeted response. The following categories outline potential causes:

Category Potential Cause Examples
Materials Substandard raw materials Non-compliance to specifications from suppliers
Method Procedural inadequacies Outdated SOPs or lack of validations
Machine Equipment failure Calibration or maintenance lapses
Man Lack of training Insufficient knowledge among operators
Measurement Inaccurate testing Defective analytical equipment
Environment Uncontrolled conditions Improper HVAC or sterile area breaches
Pharma Tip:  Inconsistent alignment with WHO TRS during remediation planning – gap remediation roadmap

Immediate Containment Actions (first 60 minutes)

The first hour following the discovery of a deviation is critical for containment. Immediate actions include:

  • Isolation: Quick identification and isolation of the affected batch or equipment to prevent further processing.
  • Notification: Alerting QA, Production, and relevant team members about the deviation.
  • Documentation: Accurate and detailed record-keeping of observed symptoms and preliminary investigation findings.
  • Assessment: Conducting an initial assessment to determine potential impact and scope.
  • Temporary Measures: Implementing temporary measures to resume operations safely while maintaining compliance.

Investigation Workflow (data to collect + how to interpret)

A structured investigation workflow is essential for identifying the root cause effectively. The following steps are recommended:

  1. Data Collection: Gather all relevant data, including batch records, equipment logs, calibration records, and any anomalies noted during the process.
  2. Sample Analysis: Analyze retained samples to check for deviations or changes in critical quality attributes.
  3. Interviews: Conduct interviews with operators and staff involved in the process to gather insights.
  4. Trend Analysis: Assess historical data and trends that may correlate with the incident, including previous findings.

Interpreting data effectively requires a comprehensive understanding of production processes and quality metrics. Look for patterns and anomalies and identify any recurring issues that could indicate systemic failures.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Choosing the appropriate root cause analysis tool is pivotal for effective problem resolution. Here’s a brief overview of three widely-used methods:

  • 5-Why Analysis: Ideal for simple problems where the cause can be traced back through a series of inquiries; effective for straightforward deviations.
  • Fishbone Diagram: Useful for exploring complex issues; this visual tool helps categorize potential causes into logical groupings (e.g., method, machine).
  • Fault Tree Analysis: Best suited for highly technical or systemic failures; this deductive reasoning diagram allows teams to map out potential failure paths.

Selecting the right tool depends on the complexity of the issue and the data available.

CAPA Strategy (correction, corrective action, preventive action)

A robust CAPA strategy ensures that not only is the immediate problem addressed, but future occurrences are mitigated as well. The strategy is broken down into:

  • Correction: Take immediate actions to rectify the identified issue, such as replacing a defective machine.
  • Corrective Action: Develop mechanisms for preventing recurrence, which could involve revising SOPs or implementing additional training protocols.
  • Preventive Action: Identify and minimize risks through continuous process improvement initiatives, such as revisiting raw material approval processes and supplier evaluation.
Pharma Tip:  Inadequate WHO GMP training during API sourcing – avoiding repeat WHO observations

Document each step of the CAPA process diligently to showcase compliance during inspections.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

A well-defined control strategy is essential to ensure ongoing compliance with WHO GMP standards. Key components include:

  • Statistical Process Control (SPC): Implementing SPC allows for ongoing monitoring of critical process parameters, identifying trends before they escalate into non-conformities.
  • Sampling Plans: Establish effective sampling plans based on risk assessments to confirm quality attributes consistently.
  • Alarm Systems: Use alarms for critical control points to trigger immediate responses for deviations.
  • Verification Procedures: Regularly verify controls through audits and reviews to confirm they remain effective over time.

Regular monitoring and oversight validate process performance and help maintain compliance in a proactive manner.

Validation / Re-qualification / Change Control impact (when needed)

Changes to process, equipment, or materials often necessitate re-validation or re-qualification to ensure continued compliance. Considerations include:

  • Validation: Any significant changes to processes or systems must undergo validation following established protocols to confirm their safety and efficacy.
  • Re-qualification: Changes in equipment or environment may require re-qualification to ensure compliance with operational standards.
  • Change Control: Adopt a structured change control process to manage changes effectively, including risk assessments and documentation of impacts.

Maintain robust documentation for any changes and evaluations to support compliance readiness and inspections.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

Demonstrating readiness for WHO inspections requires comprehensive documentation. Key documents include:

  • Training Records: Evidence of employee training sessions, including materials and attendance logs.
  • Batch Records: Detailed batch production records highlighting every step of the process, including deviations and corrective actions taken.
  • Logs: Maintenance and calibration logs for equipment ensuring they are in good working condition.
  • Deviation Reports: Complete reports for any deviations, including investigation results and CAPA plans.

Ensure all records are accurate and readily accessible during inspections to demonstrate compliance effectively.

Pharma Tip:  Inconsistent alignment with WHO TRS during API sourcing – gap remediation roadmap

FAQs

What is WHO GMP compliance?

WHO GMP compliance ensures that pharmaceutical products are consistently produced and controlled according to quality standards set by the World Health Organization.

How can I prepare for a WHO inspection?

Preparation involves comprehensive documentation, training employees, and ensuring adherence to SOPs and other quality policies.

What are the key aspects of CAPA in pharmaceutical manufacturing?

CAPA includes correction, corrective actions to prevent recurrence, and preventive actions to mitigate risk in the future.

How often should I conduct internal audits?

Internal audits should be conducted regularly, at least annually, or after significant process changes or findings in previous audits.

What documents are critical during a WHO inspection?

Critical documents include batch records, training logs, deviation reports, maintenance logs, and any CAPA documentation.

Related Reads

How do I identify the root cause of a GMP deviation?

Use structured tools like the 5-Why analysis or Fishbone diagrams to map out possible causes and investigate further based on trends and data.

What role does data analytics play in maintaining GMP compliance?

Data analytics helps in trend analysis, monitoring process performance, and identifying outliers or non-conformities in real-time.

Could equipment malfunctions lead to inspection failures?

Yes, equipment malfunctions can lead to deviations in quality, leading to potential non-compliance during inspections.

What should I do if a deviation is detected?

Immediately isolate the affected product, notify relevant teams, document the findings, and perform a root cause analysis to rectify the issue.

How is validation impacted during a WHO inspection?

Validation ensures that processes and products meet established quality standards; non-compliance can lead to regulatory actions and repeated observations.

What is the significance of change control in GMP compliance?

Change control ensures that any modifications to processes, systems, or equipment are systematically evaluated and validated to maintain compliance.

How can statistical process control (SPC) enhance quality assurance?

SPC enables continuous monitoring of critical process parameters, allowing for timely interventions before quality issues escalate.